Firebrick Pharma Limited (FRE.AX)
AUD 0.08
(0.0%)
AUD 0.08
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.34 Million | -5.78 Million | -4.2 Million | -1.93 Million | -985 Thousand | -1.06 Million |
| Net Income | -1.17 Million | -6.8 Million | -3.79 Million | -2.43 Million | -1.49 Million | -725.25 Thousand |
| Depreciation & Amortization | 7179.00 | 9519.00 | 6938.00 | 520.00 | 301.00 | 451.00 |
| Deferred income taxes | - | 978.83 Thousand | -983.97 Thousand | -555.54 Thousand | -190.22 Thousand | - |
| Stock-based compensation | -91.00 | 2106.00 | 303.69 Thousand | 534.83 Thousand | 303.99 Thousand | - |
| Change in working capital | -935.65 Thousand | 1 Million | -716.55 Thousand | -32.41 Thousand | 209.17 Thousand | -429.74 Thousand |
| Other non-cash items | -240.45 Thousand | -978.83 Thousand | 983.97 Thousand | 555.54 Thousand | 190.22 Thousand | 425 Thousand |
| Investing Cash Flow | -134.00 | -1616.00 | -32.54 Thousand | -16.06 Thousand | - | - |
| Investments in PPE | -134.00 | -1616.00 | -32.54 Thousand | -16.06 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 815.21 Thousand | 996.65 Thousand | 10.22 Million | 3.01 Million | 500.25 Thousand | 1.25 Million |
| Debt repayment | - | - | -109.06 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5291.00 | -6261.00 | -474.08 Thousand | - | - | - |
| Common Stock Issuance | 820.5 Thousand | 996.65 Thousand | 10.7 Million | 3.01 Million | 500.25 Thousand | 1.25 Million |
| Other Financing Activities | 815.21 Thousand | 6261.00 | 109.06 Thousand | 3.01 Million | 500.25 Thousand | - |
| Accounts receivables | -813.59 Thousand | 944.24 Thousand | -578.48 Thousand | 51.43 Thousand | -52.23 Thousand | -377.21 Thousand |
| Accounts payables | -240.45 Thousand | 55.73 Thousand | 195.32 Thousand | -71.1 Thousand | 166.6 Thousand | 43.19 Thousand |
| Inventory | -167.79 Thousand | - | -283.24 Thousand | - | - | - |
| Other working capital | 45.74 Thousand | 7110.00 | -50.15 Thousand | -12.75 Thousand | 94.8 Thousand | -95.73 Thousand |
| Cash at beginning of period | 2.35 Million | 7.14 Million | 1.15 Million | 92.7 Thousand | 577.46 Thousand | 382.87 Thousand |
| Cash at end of period | 824.77 Thousand | 2.35 Million | 7.14 Million | 1.15 Million | 92.7 Thousand | 577.46 Thousand |
| Capital Expenditure | -134.00 | -1616.00 | -32.54 Thousand | -16.06 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.52 Million | -4.78 Million | 5.99 Million | 1.05 Million | -484.75 Thousand | 194.58 Thousand |
| Free Cash Flow | -2.34 Million | -5.78 Million | -4.23 Million | -1.95 Million | -985 Thousand | -1.06 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.17 Million | -138.72 Thousand | -138.72 Thousand | -898.41 Thousand | -449.2 Thousand | -6.8 Million |
| Depreciation & Amortization | 7179.00 | 1785.00 | 1785.00 | 3609.00 | 1805.00 | 9519.00 |
| Deferred income taxes | - | - | - | - | - | 978.83 Thousand |
| Stock-based compensation | - | - | - | -46.00 | -46.00 | 2106.00 |
| Change in working capital | -1.17 Million | -467.82 Thousand | -467.82 Thousand | - | - | 1 Million |
| Other non-cash items | 1.23 Million | -60.65 Thousand | -60.65 Thousand | -112.01 Thousand | -59.57 Thousand | -978.83 Thousand |
| Investing Cash Flow | -134.00 | -4.00 | -4.00 | -125.00 | -63.00 | -1616.00 |
| Investments in PPE | -134.00 | -4.00 | -4.00 | -125.00 | -63.00 | -1616.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 815.21 Thousand | 425.33 Thousand | 425.33 Thousand | -35.45 Thousand | -17.72 Thousand | 996.65 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -6261.00 |
| Common Stock Issuance | 815.21 Thousand | 804.92 Thousand | - | 10.29 Thousand | - | 996.65 Thousand |
| Other Financing Activities | - | 425.33 Thousand | 425.33 Thousand | -17.72 Thousand | -17.72 Thousand | 6261.00 |
| Accounts receivables | -813.59 Thousand | -406.79 Thousand | -406.79 Thousand | - | - | 944.24 Thousand |
| Accounts payables | -240.45 Thousand | - | - | - | - | 55.73 Thousand |
| Inventory | -167.79 Thousand | -83.89 Thousand | -83.89 Thousand | - | - | - |
| Other working capital | 45.74 Thousand | 22.87 Thousand | 22.87 Thousand | - | - | 7110.00 |
| Cash at beginning of period | 2.35 Million | 1.3 Million | - | 2.35 Million | - | 7.14 Million |
| Cash at end of period | 824.77 Thousand | 824.77 Thousand | -240.09 Thousand | 1.3 Million | -524.8 Thousand | 2.35 Million |
| Capital Expenditure | -134.00 | -4.00 | -4.00 | -125.00 | -63.00 | -1616.00 |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | -1.52 Million | -480.18 Thousand | -240.09 Thousand | -1.04 Million | -524.8 Thousand | -4.78 Million |
| Free Cash Flow | -2.34 Million | -665.42 Thousand | -665.42 Thousand | -1.01 Million | -507.08 Thousand | -5.78 Million |
6117
SUNI
6775
POS
STBA
CHEMPLASTS